Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neoplasms 5Lung Neoplasms 3Anxiety Disorders 3Solitary Pulmonary Nodule 2Paresthesia 2Multiple Pulmonary Nodules 2Hypesthesia 2Dyspnea 2Depression 2Brain Neoplasms 2Surgical Wound Infection 1Skin Neoplasms 1Radiation Injuries 1Pulmonary Atelectasis 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Prostatic Diseases 1Postoperative Complications 1Pain 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia 1Inflammatory Bowel Diseases 1Hypoxia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 287Nivolumab 258Ipilimumab 236Cyclophosphamide 135aldesleukin 134Interleukin-2 104Temozolomide 75Dacarbazine 74trametinib 70Vemurafenib 69fludarabine 68dabrafenib 65fludarabine phosphate 62sargramostim 44binimetinib 44Radiosurgery 44Biopsy 43Paclitaxel 42Bevacizumab 42incomplete Freund's adjuvant 39encorafenib 37Radiotherapy 36Cisplatin 36CTLA-4 Antigen 36atezolizumab 35Carboplatin 35Magnetic Resonance Spectroscopy 33cobimetinib 32Specimen Handling 31Introns 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Melanoma × Oxygen × Clear all
NCT03716193 2026-02-27

Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry

West Virginia University

Phase NA Terminated
3 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡